Navigation Links
Tragara Initiates Clinical Study of TG02 in Combination with Carfilzomib in Multiple Myeloma
Date:12/3/2013

demonstrated both single agent activity and synergy when administered with current standard of care therapies. Subsequent development will focus on an important group of solid tumors with unmet medical need, such as small cell lung cancer, triple negative breast cancer, and melanoma, which will also benefit from this mechanism of action, complemented with the benefits of inhibiting both JAK2 and ERK5. These pathways affect disease progression and survival in hematologic malignancies and solid tumors.

TG02 is currently being evaluated in two separate phase I clinical trials in patients with MM and CLL in the United States.    

In early 2010, TG02 was selected by the Multiple Myeloma Research Foundation as a winner of its Biotech Investment Award, which represents a multi-year research grant commitment to fund the early-stage drug development of novel compounds that show potential in treating MM.

About Tragara
Tragara Pharmaceuticals, Inc. is a privately held pharmaceutical company based in San Diego, Calif. The company is focused on the clinical and commercial development of proprietary medicines for the treatment of cancer. TG02 is a unique, oral multi-kinase inhibitor which combines the benefits of inhibiting important cyclin dependent kinases equipotently with JAK2, FLT3, and ERK5 inhibition. TG02 exerts its antitumor activity via its potent CDK9 inhibition, which leads to the depletion of key survival proteins, such as Mcl-1, resulting in p53-independent apoptosis of a wide range of tumor cells. Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics. Its investors include: Domain Associates, Mitsubishi International Corporation, Morgenthaler Ventures, ProQuest Investments and RusnanoMedInvest.

Tragara strives to provide much-needed therapies that will contribute to patient health through better surv
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. UK initiates first cancer reporting model of its kind in US
2. South Charlotte Dentistry Initiates New Emphasis on Comprehensive Dental Treatment
3. Taglich Brothers Initiates Coverage on FluroPharma Medical, Inc.
4. HCG Drops 411 Initiates 21 Pound Guarantee
5. Grant initiates new stem cell research for patients suffering with corneal blindness
6. Targeted Medical Pharma Initiates Clinical Trial of Red Blood Cell Stimulating Formulation
7. Scott Sheldon Initiates Change in Consulting Industry
8. First targeted nanomedicine to enter human clinical studies
9. Clinical insight improves treatment with new lung cancer drug
10. Clinical news alert from the American Academy of Orthopaedic Surgeons
11. NYU Langone experts present research, clinical advances at neurosurgeons meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 26, 2014 News ... showcase expanded capabilities at RSNA 2014 in Chicago. ... manage and share diagnostic images, photos, videos and ... Perceptive’s booth #8107 will learn more about these ... acquired technologies and partner initiatives – that enable ...
(Date:11/26/2014)... One of the most important and vital decisions a ... is choosing the ideal wedding dress and bridesmaid dresses. ... high quality outfits. Today, BellasDress.com has unveiled its new ... their suitable bridesmaid gowns here at discount prices. , ... scintillating and highlight all their most beautiful features while ...
(Date:11/26/2014)... News) -- Vultures have developed highly specialized ways of ... dead animals, researchers report. The new research investigated ... and in the guts of 50 turkey vultures and ... faces of the vultures had more than 500 different ... the study found. The findings suggest that a ...
(Date:11/26/2014)... of emergency department visits in the United States rose from ... in 2011, according to the U.S. Centers for Disease Control ... were going to ERs with non-urgent medical needs: 96 percent ... hours of arriving at the ER. In 2010, that number ... of patients arrived at the ER after normal business hours ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. ... the U.S. Food and Drug Administration will have many restaurant ... even apply to movie theater popcorn and ice cream parlor ... away from home, often consuming less nutritious food and underestimating ... during a Monday afternoon news conference. Although listing ...
Breaking Medicine News(10 mins):Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... Oct. 29 /PRNewswire/ - Halogen Software Inc., the ... software,today announced that Vonage has selected Halogen eAppraisal ... services, is,moving to a Web-based system to streamline ... focus on delivering top-notch services to its,customers. ...
... American Football players has found that more than a third ... , In his study of homosexuality among sportsmen in the ... sample of 47 had taken part in acts intended to ... and oral sex. , The 47 men, aged 18-23, were ...
... When cells become cancerous, the sugars on their ... healthy cells. For decades, scientists have tried to exploit ... cancerous cells before they can spread and ravage the ... Cancer Center have synthesized a carbohydrate-based vaccine that ...
... LOS ANGELES, Oct. 28 Disparities in access ... socioeconomically disadvantaged populations from receiving needed cancer services ... determine the lasting impact of cancer education geared ... Medical Center (UPMC), in partnership with The Centers ...
... Research on Cancer (IARC) have now added breast cancer ... where alcohol is a contributing cause. Even moderate consumption ... day increases a womans breast cancer risk by 7%-10%. ... Toronto Cancer Prevention Coalition and the Centre for Addiction ...
... Growth Plans, DALLAS, Oct. 29 Crdentia ... company, today announced it has,completed a private placement ... this offering will be used for working capital ... focusing on internal,organic growth throughout the Sun Belt ...
Cached Medicine News:Health News:Vonage Selects Halogen Software - New Solution to Streamline Employee Performance and Talent Management Across Organization 2Health News:Over one-third of former American football players had sexual relations with men, study says 2Health News:Over one-third of former American football players had sexual relations with men, study says 3Health News:UGA researchers 1 step closer to elusive cancer vaccine 2Health News:UGA researchers 1 step closer to elusive cancer vaccine 3Health News:Education program leads to lasting improvement of cancer knowledge in African-Americans 2Health News:Alcohol and cancer -- recent research and prevention opportunities 2Health News:Crdentia Announces Completion of $5M Financing 2Health News:Crdentia Announces Completion of $5M Financing 3
(Date:11/26/2014)... Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... corporate presentations at two upcoming investor conferences.  , ... on Tuesday, December 2, 2014 at 6:45 a.m. EST ... and head of EUSA International, will provide an overview of the ... Annual Piper Jaffray Healthcare Conference in New York, ...
(Date:11/26/2014)... Nov. 26, 2014 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based on ... unaudited financial results for the third quarter ended September 30, ... 2014: , Same store sales increased by 8.1% ... Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) compared ...
(Date:11/24/2014)... , Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. ... conducted in Melbourne, Australia ... the potential treatment of paroxysmal supraventricular tachycardia (PSVT).  ... MSP-2017 was well tolerated at single doses up ... safety profile, desirable PK properties including rapid onset, ...
Breaking Medicine Technology:Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... primers and a FAM-labeled probe that is designed ... probe to detect Flu B. In addition, this ... for a separate sample processing control. This ASR ... 532 and Texas Red reporter dyes such as ...
...
Digital Ultrasonic Diagnostic Imaging System...
...
Medicine Products: